CD8A and hepatocellular carcinoma: Such associations are supported by previous studies that GranBlo CD8+ T cells associated with reduced cytotoxicity and PD-L1hi HCC/hepatocytes are highly prevalent in aggressive tumors – both may impair the control in tumor progression (23, 24).